Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02248662 · ClinicalTrials.gov registry record
Impact of Radiation Therapy on Breast Conservation in DCIS
A clinical trial, sponsored by Dana-Farber Cancer Institute.
- Completed
- Registry status
- 3,436
- Enrollment target
NCT02248662 is a clinical trial that has completed, run by Dana-Farber Cancer Institute. The registered enrollment target is 3,436 participants.
The verdict
NCT02248662 has completed, sponsored by Dana-Farber Cancer Institute.
- COMPLETED
- Registry status
- 3,436 participants
- Enrollment target
Study Summary
Large regional variation exists in the use of radiotherapy after breast-conserving surgery (BCS) for ductal carcinoma in situ (DCIS). Although patients who do not receive initial radiotherapy for DCIS are candidates for subsequent BCS if they experience a second breast event, many undergo mastectomy instead.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,436 participants |
| Start Date | 2013-08 |
| Est. Completion | 2017-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02248662
The ClinicalTrials.gov registry entry for NCT02248662 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 3,436 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dana-Farber Cancer Institute, which has 781 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02248662 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02248662 about?
NCT02248662 is a clinical study titled "Impact of Radiation Therapy on Breast Conservation in DCIS". Large regional variation exists in the use of radiotherapy after breast-conserving surgery (BCS) for ductal carcinoma in situ (DCIS). Although patients who do not receive initial radiotherapy for DCIS are candidates for subsequent BCS if they experience a second breast event, many undergo mastectomy...
What is the current status of trial NCT02248662?
This trial is currently completed. The enrollment target is 3,436 participants. The study started on 2013-08. Estimated completion is 2017-01.
Who is sponsoring clinical trial NCT02248662?
This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.